Go to content

European Society for ME - Research & Knowledge

  • ESME
  • Contact
  • Home
  • Danish Conference
  • Recent UPDATES
  • ESME
  • News
  • ME - Facts and Figures
  • Treatment
  • Testing
    • Viruses
    • Parasites
    • Bacteria
    • General ME Blood Work
    • Immunology
    • Bloth Clotting Defects
    • PCR Testing
    • Heavy Metals
    • Leaky Gut
    • Food Intolerances
    • Fructose/ Lactose Breath Testing
    • Testing Forms
  • Kids
  • Resources/Guidelines
  • Public Conferences
  • Media
  • Donate
  • Comments
  • XMRV

You are here:

  • Home
  • Testing
  • Fructose/ Lactose Breath Testing
  • Fructose malabsorption and lactose intolerance

Fructose malabsorption and lactose intolerance

In a study of 143 patients fructose malabsorption was found in 45.8% of patients. Lactose intolerance was found in 20.3%. Both can be measured via a simple hydrogen breath test. 25 grams of fructose or lactose is administered to a fasting patient. Breath hydrogen levels are measured before administration and at 30 minute intervals for 3.5 hours. Sugar malabsorption contributes to intestinal dysbiosis, among other issues. Fructose malabsorption is treated with a fructose poor diet, while lactose intolerance is treated with a lactose free diet. A high baseline hydrogen breath measurement indicates intestinal bacterial overgrowth. Clinicians can buy the equipment to do the fructose and lactose breath testing in their offices. Prof De Meirleir believes these intolerances were present before the illness onset, acting as a predisposing factor and may also get worse after illness onset. He observes these issues are often present in family members.

 

Common associations with fructose malabsorption are:

a.. Fatty liver. Most patients with fatty liver have fructose malabsorption.
b.. Steatorrhea (fat in the stool/fat malabsorption).
c.. Constipation whereas those with lactose intolerance are more likely to have diarrhoea.
d.. Hypoglycemia. Most patients with significant hypoglycemia have fructose malabsorption.
e.. Sensitivity to tyramine.
f.. Bloating.

 

Source: Dr. Kenny De Meirleir's lecture on ME/CFS - Perth - November 3rd 2007.
 

ESME.com is designed, developed and hosted by Norsk Kunde & Medlemsutvikling